Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Seffalair Spiromax
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Seffalair Spiromax 12.75microg / 100microg/dose dry pdr inh
0302000N0BQAABR
|
Seffalair Spiromax | Fluticasone propionate (Inhalation) | Respiratory System | No data available |
|
Seffalair Spiromax 12.75microg / 202microg/dose dry pdr inh
0302000N0BQABBS
|
Seffalair Spiromax | Fluticasone propionate (Inhalation) | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.